Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Current Assets (2019 - 2023)

Alx Oncology Holdings' Current Assets history spans 5 years, with the latest figure at $199.1 million for Q3 2023.

  • For Q3 2023, Current Assets fell 31.55% year-over-year to $199.1 million; the TTM value through Sep 2023 reached $199.1 million, down 31.55%, while the annual FY2022 figure was $271.0 million, 26.17% down from the prior year.
  • Current Assets for Q3 2023 was $199.1 million at Alx Oncology Holdings, down from $219.6 million in the prior quarter.
  • Across five years, Current Assets topped out at $436.0 million in Q4 2020 and bottomed at $9.8 million in Q4 2019.
  • The 5-year median for Current Assets is $290.8 million (2022), against an average of $284.1 million.
  • The largest annual shift saw Current Assets soared 4344.82% in 2020 before it tumbled 31.55% in 2023.
  • A 5-year view of Current Assets shows it stood at $9.8 million in 2019, then skyrocketed by 4344.82% to $436.0 million in 2020, then dropped by 15.82% to $367.0 million in 2021, then fell by 26.17% to $271.0 million in 2022, then dropped by 26.53% to $199.1 million in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Current Assets are $199.1 million (Q3 2023), $219.6 million (Q2 2023), and $232.5 million (Q1 2023).